← Open Payments lookup

DAVID GREENBLUM: Open Payments

NPI 1467462713 · KENSINGTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,679 in 77 payments from 12 companies in 2025. Trend: 2023 $7,756 · 2024 $12,525 · 2025 $1,679

Food & beverage: $1,679
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.18$401
Neurocrine BioSciences, Inc.8$304
Teva Pharmaceuticals USA, Inc.11$179
Otsuka America Pharmaceutical, Inc.7$158
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$141
ABBVIE INC.6$124
Supernus Pharmaceuticals, Inc.10$118
Indivior Inc.4$105
Braeburn Inc.2$60
Janssen Pharmaceuticals, Inc2$54

Products named: COBENFY, INGREZZA, CAPLYTA, UZEDY, VRAYLAR, Qelbree, SUBLOCADE, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.